GlassScriptPhysician profile
Leonard G Renfer
NPI 1235184912
$3,722.39
in general payments reported to CMS, 2019-2025
37 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $167 · 2021: $121 · 2022: $501 · 2023: $664 · 2024: $1,394 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361 · Education: $79.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,361.23 |
| Education | $79.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $423.03 | 2024 | Provenge |
| Astellas Pharma US INC | $402.47 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $390.55 | 2019-2024 | Lithovue |
| Janssen Biotech, INC. | $321.00 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Pfizer INC. | $200.76 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $164.98 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $155.16 | 2019-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter, Magic3 Intermittent Catheter |
| Abbvie INC. | $149.87 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $134.22 | 2019-2025 | Adstiladrin |
| Allergan, INC. | $133.60 | 2019-2022 | |
| Procept Biorobotics Corporation | $104.50 | 2024 | Aquabeam System |
| Verity Pharmaceuticals INC. | $101.17 | 2024-2025 | Tlando, Trelstar |
| Accord Healthcare, INC. | $100.80 | 2022-2024 | |
| Ambu INC. | $96.06 | 2024 | |
| Urovant Sciences INC | $80.15 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $77.86 | 2022-2023 | Lynparza |
| Coloplast Corp | $77.25 | 2022-2024 | Coloplast Tfl Drive, Altis, Porges Coloplast |
| Myriad Genetic Laboratories, INC. | $69.98 | 2022-2025 | Myrisk |
| Rochester Medical Corporation | $56.92 | 2020-2022 | |
| Urogen Pharma, INC. | $44.52 | 2022-2023 | |
| Becton, Dickinson and Company | $43.93 | 2024 | Bard Urinary Drainage Bag |
| Teleflex LLC | $43.47 | 2023 | Urolift |
| Angiodynamics, INC. | $39.02 | 2021-2023 | Nanoknife |
| Dentsply Ih Ab | $32.50 | 2024 | Lofric |
| Convatec INC. | $29.90 | 2024 | |
| Progenics Pharmaceuticals, INC. | $25.42 | 2022 | |
| Endo USA, INC. | $23.95 | 2024 | Xiaflex, Aveed |
| Olympus America INC. | $23.82 | 2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $23.71 | 2022 | |
| Agiliti Surgical, INC. | $21.70 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Axonics, INC. | $20.97 | 2024 | Axonics |
| Telix Pharmaceuticals | $20.91 | 2024 | Illuccix |
| Tolmar, INC. | $20.55 | 2024 | |
| Amgen INC. | $18.84 | 2022 | |
| Sumitomo Pharma America, INC. | $17.36 | 2023 | Gemtesa |
| Palette Life Sciences, INC. | $17.31 | 2021 | |
| Myovant Sciences INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Renfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.